Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCMC Markets Regulatory News (CMCX)

Share Price Information for CMC Markets (CMCX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 254.00
Bid: 255.00
Ask: 256.00
Change: 0.00 (0.00%)
Spread: 1.00 (0.392%)
Open: 254.00
High: 259.50
Low: 254.00
Prev. Close: 254.00
CMCX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

H1 2022 Pre-Close Trading Update

7 Oct 2021 07:00

RNS Number : 2660O
CMC Markets Plc
07 October 2021
 

7 October 2021

CMC Markets Plc

 

H1 2022 Pre-Close Trading Update

For the six months ended 30 September 2021

 

Reiterating FY guidance; increased relative contribution from the non-leveraged business continues

CMC Markets Plc ("CMC" or "the Group"), a leading global provider of online trading and institutional ("B2B") platform technology solutions, today issues a trading update for the six months to 30 September 2021 ("H1 2022" or "the period").

 

Key Highlights

 

· H1 2022 net operating income expected to be approximately £126 million. FY 2022 net operating income guidance reiterated at £250-280 million.

· H1 2022 leveraged gross client income is expected to be approximately £127 million (H1 2021: £174 million).

· H1 2022 leveraged net trading revenue is expected to be approximately £100 million (H1 2021: £200 million).

· H1 2022 non-leveraged net trading revenue is expected to be approximately £24 million (H1 2021: £26 million) representing 19% of Group net operating income versus 11% in H1 2021.

· Announced the acquisition of over 500,000 share investing clients of Australia and New Zealand Banking Group Limited ("ANZ"), with total assets in excess of AUD$45 billion which is due to complete in the next 12-18 months.

 

 

Trading Update

CMC reiterates prior guidance and expects FY 2022 net operating income to settle in a range between £250-280 million. Overall client AUM remains near record levels. H1 2022 active clients are moderately lower compared to H1 2021, nevertheless the monthly trading client numbers continue to remain at similar levels to those reported earlier in the year. Increased market activity exiting September led to improved client trading volumes. 

H1 2022 leveraged net trading revenue is expected to be approximately £100 million (H1 2021: £200 million). The Group's non-leveraged net trading revenue is expected to be approximately £24 million for H1 2022 (H1 2021: £26 million). In H1 our Australian stockbroking business experienced the highest AUM on record and finished the period with the highest number of monthly active clients for the year to date. H1 2022 non-leveraged net trading revenue is expected to represent some 19% of total Group net operating income, marking a new high for CMC.

During September 2021 CMC announced the acquisition of over 500,000 Share Investing clients from ANZ, bringing to an end the existing white label partnership. Ownership of these clients will continue to support multi-year growth in the region and remains core to our non-leveraged growth strategy.

 

Operating costs for H1 2022, excluding variable remuneration, are expected to be approximately £84 million (H1 2021: £79 million). As already highlighted, this is primarily a result of the Group's continued investment in technology which has resulted in higher personnel costs.

 

The results for the six months ended 30 September 2021 will be announced on 17 November 2021.

 

 

Lord Cruddas, Chief Executive Officer, commented:

"We closed the first six months with a pickup in market volatility and client trading volumes following what was a more subdued environment from the start of the year. More importantly the big event for the company was the acquisition of the ANZ stockbroking clients. This transaction, when completed (over a 12-18 month period), will boost our non-leveraged business with over 500,000 investing clients with total assets in excess of AUD$45bn. Our non-leveraged business continues to offer the greatest growth potential and now represents approximately 50 per cent of our business in Australia and near 20 per cent of the business overall. This is the highest proportional level since we launched our non-leveraged platforms. This is even before we integrate the ANZ transaction. We are on a fast track to diversification, using our existing platform technology to win B2B and B2C non-leveraged business. This will be further boosted with the launch of our new UK investment platform, which will offer both B2C and B2B potential. We look forward to updating you more in our H1 results on 17th November 2021".

 

Enquiries

CMC Markets Plc

James Cartwright, Investor Relations investor.relations@cmcmarkets.com

Euan Marshall, Chief Financial Officer

 

Camarco +44 (0) 20 3757 4994

Geoffrey Pelham-Lane

Ed Gascoigne-Pees

Jennifer Renwick

 

Notes to Editors

 

CMC Markets Plc ("CMC"), whose shares are listed on the London Stock Exchange under the ticker CMCX (LEI: 213800VB75KAZBFH5U07), was established in 1989 and is now one of the world's leading online financial trading businesses. The Group serves retail and institutional clients through regulated offices and branches in 12 countries, with a significant presence in the UK, Australia, Germany and Singapore. CMC offers an award-winning, online and mobile trading platform, enabling clients to trade up to 10,000 financial instruments across shares, indices, foreign currencies, commodities and treasuries through contracts for difference ("CFDs"), financial spread bets (in the UK and Ireland only) and, in Australia, access stockbroking services. More information is available at http://www.cmcmarkets.com/group/

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTUPGGGUUPGGQQ
Date   Source Headline
8th Apr 20243:12 pmRNSDirector/PDMR Shareholding
27th Mar 20247:00 amRNSFY 2024 Pre-Close Trading Update
6th Mar 20242:37 pmRNSDirector/PDMR Shareholding
23rd Feb 202410:03 amRNSNotification Under Listing Rule 9.6.14
6th Feb 20245:08 pmRNSDirector/PDMR Shareholding
5th Feb 20247:00 amRNSCost reduction and efficiency plans
30th Jan 20249:37 amRNSDirector/PDMR Shareholding
16th Jan 20244:57 pmRNSDirector/PDMR Shareholding
8th Jan 202410:43 amRNSDirector/PDMR Shareholding
8th Jan 20247:00 amRNSTrading Statement
6th Dec 20239:54 amRNSDirector/PDMR Shareholding
1st Dec 202312:54 pmRNSDirector/PDMR Shareholding
1st Dec 202312:49 pmRNSDirector/PDMR Shareholding
1st Dec 202312:41 pmRNSDirector/PDMR Shareholding
16th Nov 20237:00 amRNSInterim Results
7th Nov 20231:58 pmRNSDirector/PDMR Shareholding
6th Oct 20233:27 pmRNSDirector/PDMR Shareholding
25th Sep 202311:11 amRNSDirector/PDMR Shareholding
18th Sep 20232:48 pmRNSHolding(s) in Company
4th Sep 20237:00 amRNSAppointment of Chief Financial Officer
25th Aug 20237:00 amRNSTrading Statement
16th Aug 20231:52 pmRNSDirector/PDMR Shareholding
9th Aug 202312:13 pmRNSDirector/PDMR Shareholding
9th Aug 202312:11 pmRNSDirector/PDMR Shareholding
9th Aug 202312:10 pmRNSDirector/PDMR Shareholding
8th Aug 202310:00 amRNSDirector/PDMR Shareholding
27th Jul 20233:27 pmRNSResult of AGM
27th Jul 20237:00 amRNSTrading Statement
21st Jul 202311:20 amRNSDirector/PDMR Shareholding
21st Jul 202310:07 amRNSDirector/PDMR Shareholding
12th Jul 202310:27 amRNSDirector/PDMR Shareholding
7th Jul 202310:09 amRNSDirector/PDMR Shareholding
7th Jul 20237:00 amRNSDirectorate Change
23rd Jun 20235:09 pmRNSNotice of AGM
13th Jun 20237:00 amRNSFinal Results
9th Jun 20237:00 amRNSInvestment in StrikeX Technologies
6th Jun 20231:48 pmRNSDirector/PDMR Shareholding
9th May 20231:34 pmRNSDirector/PDMR Shareholding
6th Apr 20233:40 pmRNSDirector/PDMR Shareholding
31st Mar 202310:56 amRNSHolding(s) in Company
27th Mar 20233:51 pmRNSTrading Statement
7th Mar 20232:49 pmRNSDirector/PDMR Shareholding
7th Feb 202311:37 amRNSDirector/PDMR Shareholding
25th Jan 20237:00 amRNSTrading Statement
9th Jan 20232:15 pmRNSDirector/PDMR Shareholding
9th Jan 202312:50 pmRNSDirector/PDMR Shareholding
6th Jan 20233:22 pmRNSDirector/PDMR Shareholding
14th Dec 202212:38 pmRNSDirectorate Change
6th Dec 20222:38 pmRNSDirector/PDMR Shareholding
21st Nov 20221:54 pmEQSCMC Markets 'to continue rolling out investment platform'

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.